throbber
202
`
`Bréves communications ~ Kurze Mitteilungen
`
`Experientia XX/4
`
`absoluten Konfiguration von
`Ableitung der
`Alkaloiden der Aspidospermingruppe durch
`optischen Vergleich mit Alkaloiden der
`Strychningruppe
`
`In einer kiirzlich veréffentlichten Mitteilung! wurde
`durch chemische Korrelation mit den in ihrer absoluten
`Konfiguration bekannten stark linksdrehenden Alkaloi-
`den 19, 20-Dihydroakuammicin (I) und Tubifolin (II) ge-
`zeigt, dass den stark rechtsdrehenden Basen Tubotaiwin
`(= 19, 20-Dihydrocondylocarpin)
`(III) und Condyfolin
`(IV) die nachstehende absolute Konfiguration zukommt.
`
`Strukturell und damit in ihrem molekularen Bau sehr
`nahe verwandt mit Tubifolin und Condyfolin sind das
`stark rechts- bzw.
`linksdrehende (+)* und (—)%-1,2-
`Dehydroaspidospermidin (V)4.
`(~—)-V zeigt
`eine
`ahnliche Molekularrotation wie
`Tubifolin und der (bisher in der Natur noch nicht ange-
`troffene) Antipode von Condyfolin. Diese drei Stoffe be-
`sitzen dasselbe chromophore Zentrum. Wodieses Zentrum
`auch immerist, es lassen sich daran réumliche Oktanden
`anlegen, die in allen drei Verbindungen die gleichen zum
`Zentrum ndchstgelegenen Substituenten in den gleichen
`Oktanden enthalten. Dem (—)-1, 2-Dehydroaspidospermi-
`din lasst sich daher die absolute Konfiguration V (dem
`rechtsdrehenden die spiegelbildliche) zuschreiben.
`Die Bildung von (+)-Quebrachamin® aus (—)-V zeigt,
`dass dem ersteren die absolute Stereochemie VI zukommt.
`(—)-Aspidospermin besitzt am C-5 die gleiche absolute
`Konfiguration wie (~—)-Quebrachamin®, so dass ihm die
`absolute Kenfiguration VII zugeschrieben werden kann.
`(—)-Vincadifformin® ([M]p =—1821°) geht durch De-
`carbomethoxylierung in (—}-V iiber und besitzt daher die
`absolute Konfiguration VIII®.
`Zur Zeit wird versucht, durch RD-Messungen unter
`Heranziehung weiterer Relais-Substanzen den vorge-
`schlagenen
`konfigurativen Zusammenhang
`zwischen
`Strychnin- und Aspidosperminalkaloiden zu erharten’.
`
`Summary, The absolute configuration of certain alka-
`loids of the Aspidospermin group is suggested.
`
`D. ScHUMANN,
`B. W. Bycrort und H. Scumip
`
`Organish-Chemisches Institut der Universitdt, Ziivich
`(Schweiz), 27. Dezember 1963.
`
`1 DP. Scaumann und H. Scumip, Helv. chim, Acta 46, 1996 (1968).
`2G. F. Smrra und M. A. Wautp, J. chem, Soc. 1963, 4002. Das (+)-
`1,2-Dehydroaspidospermidin zeigt (ooleOR = ++ 243°,
`3M. Prat, J. LE Men, M.-M. Janot, J. M. Witson, H. Bupzixre-
`wicz, L. J. Duruam, Y. NAxacawa und C, Djerassi, Tetrahe-
`dron Letters No. 7, 271 {1962}. (—)-1,2-Dehydroaspidospermidin
`zeigt [a]sOH — — 225°,
`4 Fir die relative, der stabilsten Anordnung entsprechende Kon-
`figuration dieses Alkaloids existieren gute Argumente: ®, sowie G.
`Stork und J. E. Dotrini, J. Amer. chem. Soc. 85, 2872 (1963)
`(Fussnote 9).
`IX, Bremann und G. SpireE.iter, J. Amer, chem. Soc, 84, 4578
`(1962).
`® Die franzésischen und amerikanischen Autoren haben auf Grund
`von NMR-Argumentenfiir das Alkaloid das gespannte System mit
`cis-Stellung des H-Atoms am C-13 und der Athylenbriicke am
`C-12 vorgeschlagen, was die Molekiilgestalt gegeniiber einer
`trans-Anordnung deutlich verandert; vgl. hierzu®,
`7 Dem Schweizerischen Nationalfonds danken wir fiir Unterstiit-
`zung.
`
`5
`
` 1
`
`LN
`LH
`
`re
`COOCH,
`Tubotaiwin (IIT)
`(MIGHC» + 1936°
`
`COOCH,
`19, 20-Dihydroakuammicin (I)
`[MIGHsOH _ aogs°
`
`
`
`Tubifolin (11); (MIEH#08 — gay°,
`in CHCl, — 911°, in Essigester — 962°
`
`Condyfolin (IV)
`}
`rmyEssigester +. 927°
`
`
`
`(— )-I, 2-Dehydroaspidosper-
`midin (V): [MJGeH#OH _ gaye
`
`{+)-Quebrachamin (VI)
`
`
`
`Hd A
`
`4
`
`(—)-Aspidospermin (VI1)
`
`xa
`
`cock,
`
`(— )-Vincadifformin (VIIT}
`cmype4s0H _ igaie
`
`5-Azacytidine, a New, Highly Effective
`Cancerostatic
`
`In the course of studies on the azapyrimidines as poten-
`tial inhibitors of nucleic acid biosynthesis, a method for
`the synthesis of nucleosides derived from 5-azacytosine
`has recently been developed in the laboratories}.
`Biological testing of these compoundshas revealed that
`the cytidine analogue, 5-azacytidine (5-AzCR, m.p. 230°),
`has significant antimetabolic and cancerostatic effects.
`
`‘The substance, in very small concentrations, inhibits the
`growth of some bacteria. Thus the growthof E. colt Bina
`synthetic medium is inhibited to the extent of 50% at
`concentrations of 0.25 wg 5-AzCR perml, in strong contrast
`to a weak bacteriostatic effect (50% growth inhibition at
`520 ug per ml) shown by the 6-azacytidine which also
`
`1 F, Sorm and A, Pisxata, Coll, Czech. chem. Commun., in press. -
`Czechoslovak patent application No. PV 5916-63 and PV 7093-63.
`
`CELGENE 2116
`APOTEX v. CELGENE
`IPR2023-00512
`
`

`

`iS. IV. 1964
`
`Brevi comunicazioni — Brief Reports
`
`203
`
`Table I. Effect of 5-azacytidine on lymphoid lenkaemia in AK inbred
`tice
`
`
`Table II. Effect of various cancerostatic substances on lymphoid
`leukaemia in AK inbred mice
`
`
`Doseof 5-azacytidine
`No.of leukaemic deaths
`% 20-day
`and no, of doses i.p.
`after 20 days
`survivors
`
`
`Dose and no. of
`% response®
`Substancetested
`dosesi.p.
`
`
`100 mg/kg 1
`
`10 mg/kg 5 x,
`alternate day schedule
`
`14/8
`
`o/s
`
`75»
`
`100
`
`87.5
`15/8
`5 mg/kg 7 x, daily
`
`
`4-Amino-pteroyl-
`glutamic acid
`
`5-Bis-(2-chloroethyl)-
`aminomethyluracil
`6-Azauridine
`
`0.250 mg/kg 4 x,
`alternate day schedule
`
`0.250 mg/kg 9 x,
`daily
`500 mg/kg 6 x,
`daily
`
`30.5
`
`16
`
`836.6
`
`il
`10 mg/kg 7 x,
`6-Mercaptopurine
`
`daily
`riboside
`Eight control mice died after 6.6-- 0.5 days of leukaemia. Therapy
`repENRt
`initiated always 24 h after inoculation of leukaemic cells (107). —
`“18th day after inoculation. » 1 mouse died on the tenth day of
`intestinal haemorrhage, lymphoid hypoplasia and bone-marrow de-
`pression without macroscopical or cytological signs of leukaernia.
`
`® Response is given in % increase in survival time. Therapyinitiated
`always 24 h after inoculation of leukaemic cells (10*).
`
`possesses cancerostatic activity. Another cancerostatic of
`the same type, 6-azauridine, inhibits the growthof E. coli
`B by 50% at 1300 ug per ml. The inhibitory effects of
`5-AzCRon E.coli can be reversed by uracil, uridine and
`cytidine; this clearly indicates that 5-AzCR is interfering
`with the biosynthesis of the pyrimidine components of
`the nucleic acids or with their incorporation into bio-
`polymers.
`5-AzCR is somewhat toxic to mammals. In mice of in-
`bred strain AK, the acute toxicity (LD,,) is about 150
`mg/kg. Depression of the bone marrow and the hypo-
`plastic involution of the lymphatic system are the main
`toxic manifestations.
`In agreement with these effects, the new antimetabolite
`is a potent inhibitor of the lymphoid leukaemia of the in-
`Institute of Organic Chemistry and Biochemistry,
`bred AK mice (Table I). It is remarkable that even a single
`Czechoslovak Academy of Science, Prague (Czechoslovakia),
`dose (100 mg/kg), though provoking some toxic effects,
`January 3, 1964.
`increases the survival time very considerably. The leu-
`
`
`kaemia of AK mice is relatively resistant to chemo-
`therapy, especially as compared with lymphoid leukaemia
`L1210. For comparison, the effects of various well-known
`cancerostatic agents on AK leukaemia, as determined in
`our laboratory, are listed in Table IT.
`An extensive investigation of the new cancerostatic
`substance, including clinical trials, is under way.
`
`Zusammenfassung. Die hohe bakteriostatische und can-
`cerostatische Wirkung eines neuen Antimetaboliten, 5-
`Azacytidin, wird beschrieben.
`
`F. Sor, A. PisKata,
`A, CrmAx, and J. VESELY
`
`Reaction of Gold with Collagen in vivo
`
`Gold in the form of thio-complexes is successfully used
`in the treatment of rheumatoid arthritis, one of the so-
`called collagen diseases. Although this method of treat-
`ment is comparatively old, the mode of action of gold
`complexes has not been definitely elucidated. As it can be
`assumed that reaction of gold compounds with collagen
`is similar to that of other heavy metals, we have tried to
`prove experimentally the binding of gold into the collagen
`structure.
`For this purpose collagen fibres from tail tendon of rats
`(RTT) of Wistar strain (Rattus norvegicus var. alba),
`treated with gold sodium thiosulfate (‘Sanocrysin’ —
`Dansk Chemoterapeutisk Selskab, Denmark), 2 mg/100 g
`of body weight per week, were subjected to electron
`microscope observations and to measurements of tem-
`perature of shrinkage!, swelling*, and contraction-relaxa-
`tion?.
`We have found that, in the electromicrograph of RTT
`collagen from a rat treated for 18 weeks with Sanocrysin,
`three dark bands can be detected, two of them appearing
`
`comparatively dark. These two bands, 60 and 100 A units
`wide, are 60 A units apart, The third band in the middle
`of the light band is 30 A units wide (Figure 1). As far as
`we are informed from the literature, this is the first case
`of electron microscope demonstration of the binding of
`gold with collagen under conditions in vive.
`Other methods used in our experiments were to prove
`the binding of gold with collagen in the earlier stages of
`the treatment. With the use of all methods mentioned
`above, distinct changes in the measured quantities were
`observed even after first injections of gold (Figures 2-4).
`From the results obtained, it can be assumed that inter-
`action of collagen with gold is principally similar to
`
`1G. C. Nutting and R. Borasxy, J .Amer. Leather chem. Assoc.
`48, 96 (1948),
`% J. Poucuiy and I. Vavrucn, Physical Chemistry of Colloid Sys-
`tems (SNTL, Prague 1960, in Czech.),
`8 Z. Devi and J. Rosmus, Report at the I. Conference on Collagen
`Proteins (Velke Karlovice, September 1963).
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket